KALA logo

Kala Pharmaceuticals (KALA) Long Term Liabilities

Annual Total Long Term Liabilities

$40.10 M
-$2.06 M-4.89%

31 December 2023

KALA Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$23.35 M
-$5.35 M-18.63%

30 September 2024

KALA Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KALA Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.9%-41.0%
3 y3 years-59.6%-77.8%
5 y5 years-59.5%-76.6%

KALA Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-59.6%at low-77.8%at low
5 y5 years-59.8%at low-77.8%at low
alltimeall time-68.8%+234.3%-81.8%+180.4%

Kala Pharmaceuticals Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$23.35 M(-18.6%)
June 2024
-
$28.70 M(-16.8%)
Mar 2024
-
$34.49 M(-14.0%)
Dec 2023
$40.10 M(-4.9%)
$40.10 M(+1.3%)
Sept 2023
-
$39.60 M(+1.1%)
June 2023
-
$39.16 M(+1.7%)
Mar 2023
-
$38.50 M(-8.7%)
Dec 2022
$42.16 M(-50.5%)
$42.16 M(-9.2%)
Sept 2022
-
$46.42 M(-44.5%)
June 2022
-
$83.64 M(-0.5%)
Mar 2022
-
$84.10 M(-1.3%)
Dec 2021
$85.20 M(-14.3%)
$85.20 M(-19.0%)
Sept 2021
-
$105.15 M(+0.0%)
June 2021
-
$105.12 M(+5.1%)
Mar 2021
-
$100.05 M(+0.7%)
Dec 2020
$99.39 M
$99.39 M(-0.1%)
DateAnnualQuarterly
Sept 2020
-
$99.52 M(-0.1%)
June 2020
-
$99.63 M(-0.1%)
Mar 2020
-
$99.74 M(-0.1%)
Dec 2019
$99.86 M(+0.9%)
$99.86 M(-0.1%)
Sept 2019
-
$99.96 M(-0.1%)
June 2019
-
$100.05 M(+0.0%)
Mar 2019
-
$100.05 M(+1.1%)
Dec 2018
$98.98 M(+725.2%)
$98.98 M(+501.5%)
Sept 2018
-
$16.46 M(-9.1%)
June 2018
-
$18.10 M(-8.3%)
Mar 2018
-
$19.75 M(+64.6%)
Dec 2017
$11.99 M(-90.7%)
$11.99 M(-12.1%)
Sept 2017
-
$13.64 M(-89.4%)
June 2017
-
$128.16 M(+1438.9%)
Mar 2017
-
$8.33 M(-93.5%)
Dec 2016
$128.54 M(+115.7%)
$128.54 M
Dec 2015
$59.60 M
-

FAQ

  • What is Kala Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Kala Pharmaceuticals?
  • What is Kala Pharmaceuticals annual total long term liabilities year-on-year change?
  • What is Kala Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Kala Pharmaceuticals?
  • What is Kala Pharmaceuticals quarterly long term liabilities year-on-year change?

What is Kala Pharmaceuticals annual total long term liabilities?

The current annual total long term liabilities of KALA is $40.10 M

What is the all time high annual total long term liabilities for Kala Pharmaceuticals?

Kala Pharmaceuticals all-time high annual total long term liabilities is $128.54 M

What is Kala Pharmaceuticals annual total long term liabilities year-on-year change?

Over the past year, KALA annual total long term liabilities has changed by -$2.06 M (-4.89%)

What is Kala Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of KALA is $23.35 M

What is the all time high quarterly long term liabilities for Kala Pharmaceuticals?

Kala Pharmaceuticals all-time high quarterly total long term liabilities is $128.54 M

What is Kala Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, KALA quarterly total long term liabilities has changed by -$16.24 M (-41.02%)